Skip to main content
    G

    Goodrx Holdings Inc (GDRX)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $3.47
    -0.04 (-1.14%)

    Market Cap: $1.20B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Goodrx Holdings Inc (GDRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Goodrx Holdings (GDRX) has a market cap of $1.20B and an enterprise value of $1.39B. Its share count is down 4.86% from a year earlier. Its return on invested capital of 4.33% compares with a 1.43% median across 8 similar companies.

    Total Valuation

    Enterprise value is 15.91% above the market cap, as debt exceeds cash.

    Market Cap$1.20B
    Enterprise Value$1.39B
    Latest price (Nov 17, 2026)$3.47

    Key Dates

    The next earnings report is set for Nov 17, 2026.

    Next Earnings DateNov 17, 2026
    Last Earnings DateNov 17, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.37% in the quarter ended Jun 30, 2026 and shrank 5.04% a year over 2 years.

    Shares Outstanding339.28M
    Shares Change (YoY)-4.86%
    Shares Change (QoQ)-0.37%
    Share Count Growth (2Y CAGR)-5.04%

    Valuation Ratios

    Sales and book value multiples are 1.5x and 1.8x. Its year-end P/E ranged from 7.7x to 99.0x from 2021 to 2025.

    P/E Ratio14.5x
    Forward P/E11.2x
    P/S Ratio1.5x
    Forward P/S1.5x
    P/B Ratio1.8x
    P/TBV Ratio62.9x
    P/FCF Ratio8.9x
    P/OCF Ratio5.9x
    PEG Ratio0.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 8.2x EBITDA and 10.4x free cash flow.

    EV / Earnings85.4x
    EV / Sales1.8x
    EV / EBITDA8.2x
    EV / EBIT18.4x
    EV / FCF10.4x

    Price Statistics

    The stock is up 16.84% over 52 weeks and trades 0.87% above its 50-day average.

    Beta (1Y)1.38
    52-Week Change+16.84%
    1-Month Change+2.97%
    3-Month Change-1.98%
    6-Month Change+37.70%
    5-Year Change-92.17%
    Total Return (1Y)+16.84%
    Total Return (3Y CAGR)-12.78%
    Total Return (5Y CAGR)-38.96%
    Return vs SPY (1Y)+12.81%
    Max Drawdown (1Y)-35.52%
    Max Drawdown (3Y)-79.34%
    Sharpe Ratio (1Y)0.39
    Correlation with SPY (1Y)0.34
    50-Day Average$3.44
    200-Day Average$2.88
    52-Week Range$1.77 to $3.89
    RSI (14 Days)48.2
    Average Volume (20 Days)1.14M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.38x current liabilities, and total debt is 0.75x shareholder equity.

    Current Ratio1.38x
    Quick Ratio1.38x
    Debt / Equity0.75x
    Debt / EBITDA2.93x
    Debt / FCF3.69x
    Interest Coverage1.85x

    Returns and Efficiency

    Return on invested capital is 4.33% over the last 12 months, against a 5-year average of 1.63%.

    Return on Equity (ROE)2.51%
    Return on Assets (ROA)0.69%
    Return on Invested Capital (ROIC)4.33%
    Return on Capital Employed (ROCE)6.38%
    ROE (5Y Average)-0.21%
    ROA (5Y Average)-0.17%
    ROIC (5Y Average)1.63%
    Asset Turnover0.43x
    Receivables Turnover3.79x

    Taxes

    Income tax took 60.75% of pretax income over the last 12 months.

    Income Tax (TTM)$25.15M
    Effective Tax Rate60.75%

    Scores

    GDRX has an Altman Z-Score of 0.25, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score0.25
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $785.23M over the last 12 months is down 1.83% from the 12 months before.

    Revenue$785.23M
    Revenue Growth (YoY)-1.83%
    Gross Profit$713.19M
    Operating Income$74.94M
    Pretax Income$41.40M
    Net Income$16.25M
    EBITDA$166.04M
    EBIT$75.57M
    Reported EPS (TTM)$0.24

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.68% of the $2.34B in total assets.

    Cash and Equivalents$296.11M
    Total Debt$486.59M
    Net Debt$190.47M
    Net Debt Per Share$0.56
    Working Capital$441.46M
    Shareholder Equity$647.60M
    Book Value Per Share$1.91
    Tangible Book Value$18.72M
    Tangible Book Per Share$0.06
    Total Assets$2.34B
    Total Liabilities$1.70B

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $69.88M of capital spending, operating cash flow left $131.70M of free cash flow.

    Operating Cash Flow$201.58M
    Capital Expenditures$69.88M
    Free Cash Flow$131.70M
    FCF Per Share$1.23
    Depreciation and Amortization$90.47M
    Share Repurchases$85.00M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 9.54%, against a 5-year average of 3.54%.

    Gross Margin90.83%
    Operating Margin9.54%
    Pretax Margin5.27%
    Net Margin2.07%
    EBITDA Margin21.15%
    EBIT Margin9.62%
    FCF Margin16.77%
    Gross Margin (5Y Average)92.60%
    Operating Margin (5Y Average)3.54%
    Net Margin (5Y Average)-0.59%

    Growth

    Revenue grew 1.30% a year over 3 years, and EPS 5.27% a year.

    Revenue Growth (3Y CAGR)+1.30%
    Revenue Growth (5Y CAGR)+7.67%
    EPS Growth (3Y CAGR)+5.27%
    EPS Growth (5Y CAGR)-61.77%
    FCF Growth (3Y CAGR)+0.84%
    FCF Growth (5Y CAGR)-0.34%
    Operating Income Growth (3Y CAGR)+269.24%
    Book Value Per Share Growth (2Y CAGR)-2.54%

    Revenue and profit by year

    Dividends and Yields

    GDRX does not pay a dividend. Its free cash flow yield is 11.19%.

    Earnings Yield6.90%
    FCF Yield11.19%
    Buyback Yield7.18%
    Shareholder Yield7.18%

    Peer Position

    Against 8 similar companies, GDRX has the 7th highest P/E and the 3rd highest ROIC.

    P/E Ratio14.5x vs 34.9x median
    P/S Ratio1.5x vs 2.0x median
    ROIC4.33% vs 1.43% median
    Revenue Growth (Trailing 4 Quarters, YoY)-1.83% vs +7.73% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 2.44% and EPS growth at 0.29% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2.44%
    EPS Growth Forecast (2Y CAGR)+0.29%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GDRX

    What is GDRX's market cap?

    Goodrx Holdings has a market cap of $1.20B. Its enterprise value, which adds debt and subtracts cash, is $1.39B.

    What is GDRX's P/E ratio?

    Goodrx Holdings has a trailing P/E ratio of 14.5x and a forward P/E of 11.2x.

    How many shares of GDRX are outstanding?

    Goodrx Holdings has 339.28M shares outstanding. The count is down 4.86% from a year earlier.

    Does GDRX pay a dividend?

    No. Goodrx Holdings does not pay a dividend.

    How much debt does GDRX have?

    Goodrx Holdings has $486.59M of total debt and $296.11M of cash and equivalents, a net debt position of $190.47M.